; and (D) the degree to which the solution will reduce emissions and the environmental health burden created by ethylene oxide emissions from the sterilization of medical devices. (5) Consideration In carrying out this section, the committee shall take into consideration the best practices provided for in the challenges and prizes toolkit made publicly available on December 15, 2016, by the General Services Administration. (d) Acceptance of funds In addition to such sums as may be appropriated or otherwise made available to the Director to award prizes under this section, the Director may accept funds from other Federal agencies, and State and local governments to award prizes under this section. (e) Eligibility Notwithstanding section 24(g)(3) of the Stevenson-Wydler Technology Innovation Act of 1980 ( 15 U.S.C. 3719(g)(3) ), a group may be eligible for an award under this section if 1 member of such group is a citizen or permanent resident of the United States. (f) Completion of prize competitions The prize competitions carried out under this section shall be completed not later than the date that is 5 years after the program is established under subsection (a). (g) Authorization of appropriations There is authorized to be appropriated $20,000,000 to carry out this section, to remain available until expended. 3. Agency Activities to Support Novel and Early-Stage Technology for Medical Device Sterilization (a) National science foundation During the 5 year period beginning on the date of the enactment of this Act, the National Science Foundation shall use existing authority to award grants on a competitive basis to investigator-initiated research projects that may lead to the development, implementation, and assessment of novel sterilization methods, including traineeships for those who perform this research in academic and industrial settings. (b) National institutes of health The Director of the National Institutes of Health shall— (1) support or conduct research on the health effects of— (A) novel